A kind of woman's urgent contraception medicines manual is revised

A kind of woman's urgent contraception medicines manual is revised
It is reported (Reporter and king Red) Assessed the result according to the bad reaction, in order to control medicines to use the risk, national Bureau of Drugs Supervision released the notice a few days ago, require that revises the non-prescribed medicine manual model of slice of promise progesterone of left alkyne. Compared with old edition manual, the medicines manual after revising is changed on contents such as usage consumption, bad reaction, attentive matters,etc. to some extent.
It is introduced, the left alkyne promise progesterone one is oral contraceptive non-prescription medicines, used for women's practising contraception promptly, namely use while there are no safeguard procedures or other contraceptive devices to fail.
The medicines manual after revising should be indicated in the consumption column of the usage, this medicines should take orally the first after the sexual life in 72 hours, obey the second slice after separating for 12 hours. In the intersection of bad reaction and column, indicate from the intersection of old edition and manual " accidental sick and vomiting slightly, does not generally need to deal with, can disappear by oneself " Change it for " symptom of slight nausea, vomiting, breast touch a tender spot, have a headache, dizzy, tired occasionallying etc., need, deal with generally, can disappear by oneself after 24 hour, until symptom should be consulted to the doctor while being relatively in weight " ,Increased " can see the uterus and unusually bleed, the majority is shown as and taken medicine after period of the moon is ahead of time or prolongs " at the same time; Minority show as abnormality bleed, generally can disappear by oneself, should consult to the doctor while being getting serious " One.
National Bureau of Drugs Supervision requires, regional medicine supervises the department and notifies in the area under one's jurisdiction the medicines manufacturing enterprise revises manual and label of this medicines as soon as possible, and inform the content revised of in time relevant medical organization, medicines to manage units such as enterprises,etc.. Meanwhile, the relevant medicines manufacturing enterprise should follow the security disposition condition of this kind of medicines clinical practice, collect the bad reaction and report in time voluntarily.
|